SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGPBiotechnology
+$0.45 today
- Market cap
- $993.14M
- Beta
- -0.34
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$1.32
Volume 0.10M
Average 0.09M
SGP Other Current Assets
Current assets not reported separately, such as prepaid expenses.
SpyGlass Pharma, Inc. Common StockNASDAQ: SGP
Other Current Assets · Q1 FY2026 · quarter ended Mar 2026
Other current assets of $1.71M in Q1 FY2026
Q1 FY2026 other current assets was $1.71M.
Context
- Other current assets amounted to 0.7% of total assets at the end of Q1 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Other Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
Other Current Assets vs competitors
How SGP compares with its peers on the latest reported figures
- Peers report in different currencies, so other current assets is compared through growth and share of total assets rather than absolute size.
- Other current assets amounts to 0.7% of total assets for SGP, versus a peer median of 1.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $533M USD | +15.2% | +299.2% | 1.7% | |
| Jun 2026 | $396M USD | -9.0% | -0.5% | 2.9% | |
| Jun 2026 | $31.35M USD | +129.3% | +11.7% | 3.4% | |
| Mar 2026 | $24.55M USD | +1652.5% | +195.1% | 8.5% | |
| Mar 2026 | $11.21M USD | +17.7% | +39.2% | 1.5% | |
| Mar 2026 | $4.03M USD | -11.2% | +14.0% | 1.3% | |
| Mar 2026 | $3.95M USD | +35.7% | -1.6% | 3.6% | |
SGPSpyGlass Pharma, Inc. Common Stock | Mar 2026 | $1.71M USD | — | — | 0.7% |
| Apr 2026 | $851K USD | +192.4% | +114.8% | 0.2% | |
| Mar 2026 | CHF 0 CHF | — | +65.6% | 0.0% | |
| Peer median (excluding SGP) | — | +26.7% | +39.2% | 1.7% | |
Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGP
Intrinsic Alpha fair value
Locked
Current Price
$29.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.